2
ter can be downloaded from www.fda.gov/ cdrh/psn/show16- Nellcor.html. The supplement should be retained for reference with the Fetal Heart Monitoring Principles and Practices (3rd ed.) textbook. A second printing of the third-edi- tion Fetal Heart Monitoring Principles and Practices textbook that includes all corrections and supplement updates was scheduled for release in September 2003. The second printing will be easi- ly identified as such on the reverse of the inside cover page. FDA Proposing Revisions for Blood Storage T he Food and Drug Administra- tion (FDA) is proposing to revise the labeling and storage requirements for certain human blood and blood components, including source plasma, by combining, simplifying and updat- ing specific regulations applicable to container labeling and instruction cir- culars, and the shipping and storage temperatures for frozen noncellular blood components. This proposed rule would facilitate the use of a labeling system using machine-readable information that would be acceptable as a replacement for the “ABC Codabar” system for labeling blood and blood components. FDA is taking this action as part of its “Blood Initiative” to comprehensively review and, as necessary, revise its reg- ulations, policies, guidances and pro- cedures related to the licensing and regulation of blood products. This proposed rule is intended to help ensure the continued safety of the blood supply and to help ensure con- sistency in container labeling and stor- age temperatures. Submit written or electronic com- ments on the proposed rule by October 28, 2003. See section VIII of this document for the proposed effec- tive date of a final rule based on this document. To access the ruling, go to http://frwebgate.access.gpo.gov/ cgibin/leaving.cgi?from=leavingFR. html&log=linklog&to=http://www.fda. gov/dockets/ecomments. National Test Trial Set for Diabetes Community T he National Diabetes Education Outcomes System (NDEOS), which was recently previewed at the American Association of Diabetes Educators (AADE) Annual Meeting & Exhibition, is being launched to stan- dardize measurement of outcomes in diabetes care and education. Diabetes is a costly chronic disease. In the U.S. alone, recent statistics report 17 million persons with dia- betes; the Centers for Disease Control and Prevention predict a continued sharp increase in these already acceler- ated rates. The diabetes community, patients and educators, are feeling the pressure from Medicare, third party payers and administrators to provide a more thorough reporting of specific outcomes related to diabetes educa- tion. Validation of improved patient behaviors, such as eating habits, physi- cal activity, blood glucose monitoring and medication administration, is required in order to demonstrate out- comes. Diabetes care and education team members can now use the NDEOS to aid in this necessary process. Successful treatment of diabetes requires the partnership of the patient, clinician and the diabetes edu- cator. With this new system, diabetes educators have a complete solution to gather, track and aggregate patient outcomes while integrating the prac- tice of diabetes education and clinical care. AADE reports that testing of the new system will take place from August 2003 to February 2004 in 500 to 1,000 patients at seven diabetes edu- cation sites throughout the U.S. It has projected that NDEOS will be available to the entire diabetes education com- munity by March 2004. Testing Ways to Keep Weight Off T he National Heart, Lung, and Blood Institute (NHLBI) has announced the launch of a major study that could help solve one of the hardest aspects of weight loss—keep- ing off lost pounds. The study, called the “Weight Loss Maintenance Trial,” will be done in two phases at four clin- ical sites. The study will include 1,600 men and women in its first phase, and 800 in its second. Phase I is a five-month weight loss program; Phase II will try to help those who lose nine or more pounds in Phase I keep the weight off for two and a half years. The study has begun seeking par- ticipants, who must be overweight or obese, age 25 or older, and taking medication to control high blood pres- sure and/or high blood cholesterol. About 60 percent will be women and 40 percent will be African American. Overweight/obesity is the second leading cause of preventable death in the U.S. Overweight and obesity increase the risk of heart disease and other conditions, including high blood pressure, high blood cholesterol, dia- betes, stroke and some cancers. About 65 percent of American adults—about 129 million persons— are overweight or obese, and the prevalence is increasing. In 1988-94, almost 60 percent of American adults were overweight or obese, while in 1999 to 2000, nearly 65 percent were overweight or obese. The four centers involved in the Weight Loss Maintenance study are Duke University October | November 2003 AWHONN Lifelines 453

Testing Ways to Keep Weight Off

  • View
    216

  • Download
    2

Embed Size (px)

Citation preview

Page 1: Testing Ways to Keep Weight Off

ter can be downloaded from

www.fda.gov/ cdrh/psn/show16-

Nellcor.html. The supplement should

be retained for reference with the Fetal

Heart Monitoring Principles and

Practices (3rd ed.)

textbook.

A second printing of the third-edi-

tion Fetal Heart Monitoring Principles

and Practices textbook that includes all

corrections and supplement updates

was scheduled for release in September

2003. The second printing will be easi-

ly identified as such on the reverse of

the inside cover page.

FDA Proposing Revisionsfor Blood Storage

The Food and Drug Administra-

tion (FDA) is proposing to revise

the labeling and storage requirements

for certain human blood and blood

components, including source plasma,

by combining, simplifying and updat-

ing specific regulations applicable to

container labeling and instruction cir-

culars, and the shipping and storage

temperatures for frozen noncellular

blood components.

This proposed rule would facilitate

the use of a labeling system using

machine-readable information that

would be acceptable as a replacement

for the “ABC Codabar” system for

labeling blood and blood components.

FDA is taking this action as part of its

“Blood Initiative” to comprehensively

review and, as necessary, revise its reg-

ulations, policies, guidances and pro-

cedures related to the licensing and

regulation of blood products. This

proposed rule is intended to help

ensure the continued safety of the

blood supply and to help ensure con-

sistency in container labeling and stor-

age temperatures.

Submit written or electronic com-

ments on the proposed rule by

October 28, 2003. See section VIII of

this document for the proposed effec-

tive date of a final rule based on this

document. To access the ruling, go to

http://frwebgate.access.gpo.gov/

cgibin/leaving.cgi?from=leavingFR.

html&log=linklog&to=http://www.fda.

gov/dockets/ecomments.

National Test Trial Set forDiabetes Community

The National Diabetes Education

Outcomes System (NDEOS),

which was recently previewed at the

American Association of Diabetes

Educators (AADE) Annual Meeting &

Exhibition, is being launched to stan-

dardize measurement of outcomes in

diabetes care and education.

Diabetes is a costly chronic disease.

In the U.S. alone, recent statistics

report 17 million persons with dia-

betes; the Centers for Disease Control

and Prevention predict a continued

sharp increase in these already acceler-

ated rates. The diabetes community,

patients and educators, are feeling the

pressure from Medicare, third party

payers and administrators to provide a

more thorough reporting of specific

outcomes related to diabetes educa-

tion. Validation of improved patient

behaviors, such as eating habits, physi-

cal activity, blood glucose monitoring

and medication administration, is

required in order to demonstrate out-

comes. Diabetes care and education

team members can now use the

NDEOS to aid in this necessary

process.

Successful treatment of diabetes

requires the partnership of the

patient, clinician and the diabetes edu-

cator. With this new system, diabetes

educators have a complete solution to

gather, track and aggregate patient

outcomes while integrating the prac-

tice of diabetes education and clinical

care.

AADE reports that testing of the

new system will take place from

August 2003 to February 2004 in 500

to 1,000 patients at seven diabetes edu-

cation sites throughout the U.S. It has

projected that NDEOS will be available

to the entire diabetes education com-

munity by March 2004.

Testing Ways to KeepWeight Off

The National Heart, Lung, and

Blood Institute (NHLBI) has

announced the launch of a major

study that could help solve one of the

hardest aspects of weight loss—keep-

ing off lost pounds. The study, called

the “Weight Loss Maintenance Trial,”

will be done in two phases at four clin-

ical sites.

The study will include 1,600 men

and women in its first phase, and 800

in its second. Phase I is a five-month

weight loss program; Phase II will try

to help those who lose nine or more

pounds in Phase I keep the weight off

for two and a half years.

The study has begun seeking par-

ticipants, who must be overweight or

obese, age 25 or older, and taking

medication to control high blood pres-

sure and/or high blood cholesterol.

About 60 percent will be women and

40 percent will be African American.

Overweight/obesity is the second

leading cause of preventable death in

the U.S. Overweight and obesity

increase the risk of heart disease and

other conditions, including high blood

pressure, high blood cholesterol, dia-

betes, stroke and some cancers.

About 65 percent of American

adults—about 129 million persons—

are overweight or obese, and the

prevalence is increasing. In 1988-94,

almost 60 percent of American adults

were overweight or obese, while in

1999 to 2000, nearly 65 percent were

overweight or obese.

The four centers involved in the

Weight Loss Maintenance study are

• Duke University

October | November 2003 AWHONN Lifelines 453

Page 2: Testing Ways to Keep Weight Off

• Pennington Biomedical Research

Center at Louisiana State University

in Baton Rouge

• Permanente Center for Health

Research (KPCHR) in Portland, OR

• The Johns Hopkins Medical Institu-

tions in Baltimore, MD

In the study’s first phase, participants

will receive counseling to help them

make lifestyle changes to reduce their

weight. These lifestyle changes will

include reducing calories and increas-

ing physical activity. Participants will

be encouraged to follow the DASH

eating plan, which has been shown to

reduce blood pressure and cholesterol.

DASH is high in fiber and low in satu-

rated fat, cholesterol and total fat, and

emphasizes fruits, vegetables and low-

fat dairy foods. Phase I participants

will keep food and fitness diaries to

monitor their diet and physical activi-

ty. Those who lose nine or more

pounds after five months will be eligi-

ble to enroll in phase II.

In phase II, participants will be ran-

domly assigned to one of three weight-

maintenance strategies: self-directed/

usual care (SD/UC), personal contact

(PC), and interactive technology (IT).

The SD/UC group will meet once with

a health counselor for advice on how

to maintain their weight loss and to

discuss their own weight loss plans.

They also will receive educational mate-

rials about diet and physical activity.

Those in the PC group will receive

personal guidance and counseling on

how to maintain their weight loss

through monthly telephone calls and

occasional visits with a health coun-

selor.

Participants in the IT group will

use an Internet-based, individually tai-

lored, interactive computer program to

help them keep their weight off. They

can use the program as often as they

wish and can log on anywhere they

have Internet access: at home, work, a

school or a public library. They also

will receive weekly e-mails with tai-

lored messages on their progress that

include links to the Web site.

Furthermore, they will receive

reminders by an interactive voice

phone system to log onto the study’s

Web site and respond to e-mail.

Those interested in finding out

about enrolling in the study can call

the site near them:

for Duke University, (919) 419-5904;

for Pennington, (225) 763-2596;

for Kaiser Permanente, (503) 499-5766;

for Johns Hopkins, (410) 281-1881.

454 AWHONN Lifelines Volume 7 Issue 5

Get your next meeting or educational session listed in AWHONN Lifelines by faxing your informa-tion to: AWHONN Lifelines—Save These Dates: (970) 947-9784 or email [email protected] are included on a space-available basis.

Save These Dates!

DATE LOCATION EVENT

10/10-13 Los Angeles, CA Women's Health Practice Update and Certification Preparation Course; UCLA Research & Education Institute; contact www.womenshealthnp.org

10/15 London, Canada Breast Feeding Challenges: Complex Clinical Issues; contactMargret Duncan at (519) 685-8300 ext. 52954 or e-mail [email protected]

10/16-18 Mississauga, Canada Building Brighter Futures; AWHONN Canada Conference; contact Sue Bookey-Bassett at [email protected]

10/24 Miami, FL Improving Health Care Qualitythrough Research; Florida International University School ofNursing; contact JoAnne Youngblut at (305) 919-5845 [email protected]

11/2 Newport, OR Annual Fall Conference; AWHONN Oregon Section; contact Jane Wilson at [email protected] or (503) 215-5027

11/2-7 Santiago, Chile XVII FIGO World Congress of Gynecology & Obstetrics; www.figo2003.com

11/7-8 Toronto, Canada Breastfeeding Conference; Contact Joyce Ridge, Mount Sinai Hospital, (416) 586-3238

6/26-30, 2004 Tampa, FL Challenging the Status Quo, the AWHONN 2004 Convention, www.awhonn.org

On-going Call for location Challenging the Status Quo, theAWHONN 2004 Convention; www.awhonn.org

On-going Call for location The AWHONN Fetal Heart Monitor-ing Principles and Practices Workshop; www.awhonn.org